Good Picks Up Non-Core iNova Drugs
This article was originally published in PharmAsia News
Executive Summary
Valeant group company iNova Pharmaceuticals has entrusted sales and marketing for two non- core products to the Singaporean firm, Good Pharmaceutical, in certain Asian markets.